Authors :
Sidra Rauf; Sadia Aftab; Manahil Aftab; Zakir Jamal; Sajal Kazmi; Mazhar Jalil Khan; Faiza Mushtaq; Soha Shaukat
Volume/Issue :
Volume 8 - 2023, Issue 8 - August
Google Scholar :
https://bit.ly/3TmGbDi
Scribd :
https://tinyurl.com/y8mhdrpw
DOI :
https://doi.org/10.5281/zenodo.8311099
Abstract :
Background: Many years have passed since the severe
acute respiratory syndrome coronavirus 2 pandemic
started, no specific treatment against the disease is
available. Pregnant women are at increased risk of
severe disease, intensive care unit admission, and
invasive ventilation when compared with non-pregnant
patients of the same age. Therefore, pregnant women are
classified as a high-risk population for COVID-19
infection.
Methodology: This Cross-sectional study was conducted
at Department of Obstetrics & Gynecology, PIMS MCH,
Islamabad for a period of three months. Structured
questionnaire was given to partcipants which focused on
demographics, medical comorbidities, perception of
COVID-19 infection and risk of infection, barriers to
vaccination, preferred source of medical information,
vaccine acceptance, vaccine uptake, and reasons for
unwillingness to receive the COVID-19 vaccine decision.
Results: The study included a total of 200 pregnant
women.The mean age of the participants was 25 years,
ranging from minimum age of 19 years to maximum age
of 37 years.Conclusion: COVID-19 vaccination during pregnancy
presents an opportunity to protect both maternal and
fetal health, based on available evidence and current
understanding. While data on vaccine safety during
pregnancy is growing, it is important to acknowledge
that research is ongoing, and recommendations may
evolve as new information emerges.
Keywords :
COVID-19, Vaccination, Pregnancy, Acceptance.
Background: Many years have passed since the severe
acute respiratory syndrome coronavirus 2 pandemic
started, no specific treatment against the disease is
available. Pregnant women are at increased risk of
severe disease, intensive care unit admission, and
invasive ventilation when compared with non-pregnant
patients of the same age. Therefore, pregnant women are
classified as a high-risk population for COVID-19
infection.
Methodology: This Cross-sectional study was conducted
at Department of Obstetrics & Gynecology, PIMS MCH,
Islamabad for a period of three months. Structured
questionnaire was given to partcipants which focused on
demographics, medical comorbidities, perception of
COVID-19 infection and risk of infection, barriers to
vaccination, preferred source of medical information,
vaccine acceptance, vaccine uptake, and reasons for
unwillingness to receive the COVID-19 vaccine decision.
Results: The study included a total of 200 pregnant
women.The mean age of the participants was 25 years,
ranging from minimum age of 19 years to maximum age
of 37 years.Conclusion: COVID-19 vaccination during pregnancy
presents an opportunity to protect both maternal and
fetal health, based on available evidence and current
understanding. While data on vaccine safety during
pregnancy is growing, it is important to acknowledge
that research is ongoing, and recommendations may
evolve as new information emerges.
Keywords :
COVID-19, Vaccination, Pregnancy, Acceptance.
